Cyteir Therapeutics, Inc. (CYT) has a market capitalization of $108.71M and trades at $3.02. The 52-week range is 1.65-3.19.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -2.4, Earnings Per Share (EPS) of $-1.25.
The stock has a beta of 0.10, operates in the Healthcare sector.
